ÂÜÀòÂÒÂ×

Founder and CEO Dr. Jon Isaacsohn has more than 30 years of experience developing hundreds of drugs from protocol design to global submissions (including 30 NDAs) and was the co-founder of Medpace, Inc. He has decades of experience in academia, pharmaceuticals and clinical medicine. Dr. Isaacsohn formerly served as the Chief Medical Officer of Teva, where he was responsible for specialty drug development, including about 160 clinical trials, as well as the company’s New Therapeutic Entity Initiative, the safety of all marketed products and the Global Health Program.